Keytruda (Pembrolizumab) is indicated for the treatment of numerous cancer types. | Photocredit: Wildpixel The Iceland -based biotech company Alvotech and Dr. Laboratories. Reddy have concluded a collaboration and license agreement to develop, produce and commercialize a biosimilar candidate together to Keytruda (Pembrolizumab) for global markets. Keytruda (Pembrolizumab) is indicated for the treatment of numerous […]
